3 active not recruiting, 2 recruiting, 2 withdrawn, 1 completed. 2 Not applicable, 1 Early Phase 1, 1 Phase 1, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Recruiting 1, Withdrawn 1 |
| Early Phase 1 | 1 | Recruiting 1 |
| Phase 1 | 1 | Withdrawn 1 |
| Phase 2 | 1 | Withdrawn 1 |
| Phase 3 | 1 | Active not recruiting 1 |
Follow Stage II Ovarian Cancer AJCC v8: new trials by email Literature Review of Stage II Ovarian Cancer AJCC v8 trials Research Report on Stage II Ovarian Cancer AJCC v8
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Virtual Mental Health Intervention to Address Fear of Progression for Women With High Risk or Stage III-IV Gynecologic or Breast Cancer Behavioral Intervention, Educational Intervention, Internet-Based Intervention - Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8 | Not applicable | Withdrawn | City of Hope Medical Center | 2026-07-16 | 2026-02-04 | |
| Effects of a Probiotic Intervention on the Gut and Vaginal Microbiome in Patients With Advanced or Recurrent Ovarian Cancer Undergoing Treatment With Platinum Chemotherapy Biospecimen Collection, Placebo Administration, Probiotic - Advanced Ovarian Carcinoma, Recurrent Ovarian Carcinoma | Early Phase 1 | Recruiting | Ohio State University Comprehensive Cancer Center | 161 | 2026-03-06 | 2026-08-17 |
| An Automated Personalized Physical Activity Intervention to Improve Immune Function and Clinical Outcomes in Stage II-IV Ovarian, Primary Peritoneal or Fallopian Tube Cancer and Newly Diagnosed Endometrial Cancer, Life on the Go 3 Study Behavioral Intervention, Best Practice, Biospecimen Collection - Endometrial Carcinoma, Recurrent Fallopian Tube Carcinoma | Not applicable | Recruiting | Roswell Park Cancer Institute | 120 | 2025-06-04 | 2026-01-06 |
| Specialized Immune Cells (nCTLs) and a Vaccine (Alpha-type-1 Polarized Dendritic Cells) in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Alpha-type-1 Polarized Dendritic Cells, Autologous Natural Killer Cell-like CTLs - Stage II Fallopian Tube Cancer AJCC v8, Stage II Ovarian Cancer AJCC v8 | Phase 1 / Phase 2 | Withdrawn | Roswell Park Cancer Institute | 2023-12-15 | 2023-11-22 | |
| Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer Survivors Medical Device Usage and Evaluation, Quality-of-Life Assessment, Survey Administration - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8 | Active not recruiting | University of Southern California | 173 | 2021-11-24 | 2026-10-05 | |
| Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes Patient Monitoring, Questionnaire Administration - Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8, Clinical Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8 | Completed | City of Hope Medical Center | 22 | 2020-08-11 | 2026-10-14 | |
| Letrozole With or Without Paclitaxel and Carboplatin in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Biopsy Procedure, Biospecimen Collection, Carboplatin - Low Grade Fallopian Tube Serous Adenocarcinoma, Ovarian Low Grade Serous Adenocarcinoma | Phase 3 | Active not recruiting | NRG Oncology | 450 | 2019-09-20 | 2026-03-24 |
| Treatment Effects on Development of Chemotherapy-Induced Peripheral Neuropathy in Patients With Cancer Chemotherapy, Functional Assessment, Questionnaire Administration - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8 | Active not recruiting | SWOG Cancer Research Network | 1336 | 2019-05-14 | 2026-10-02 |
Ovarian Neoplasms (8) · Fallopian Tube Neoplasms (3) · Colorectal Neoplasms (2) · Endometrial Neoplasms (2) · Uterine Cervical Neoplasms (2) · Bone Neoplasms (1) · Brain Neoplasms (1) · Carcinoma, Medullary (1) · Carcinoma, Non-Small-Cell Lung (1) · Carcinoma, Renal Cell (1) · Central Nervous System Neoplasms (1) · Gastrointestinal Neoplasms (1) · Genital Neoplasms, Female (1) · Hodgkin Disease (1) · Lung Neoplasms (1)
Adnexal Diseases (8) · Endocrine Gland Neoplasms (8) · Endocrine System Diseases (8) · Female Urogenital Diseases (8) · Female Urogenital Diseases and Pregnancy Complications (8) · Genital Diseases (8) · Genital Diseases, Female (8) · Gonadal Disorders (8) · Neoplasms by Site (8) · Ovarian Diseases (8) · Urogenital Diseases (8) · Genital Neoplasms, Female (7) · Neoplasms (7) · Urogenital Neoplasms (7) · Uterine Diseases (4)
Specimen Handling (3) · Behavior Therapy (2) · Biopsy (1) · Carboplatin (1) · Drug Therapy (1) · Early Intervention, Educational (1) · Educational Status (1) · Fluid Therapy (1) · Interviews as Topic (1) · Letrozole (1) · Methods (1) · Paclitaxel (1) · Palliative Care (1) · Powders (1) · Practice Guidelines as Topic (1)
City of Hope Medical Center (2) · Roswell Park Cancer Institute (2) · NRG Oncology (1) · Ohio State University Comprehensive Cancer Center (1) · SWOG Cancer Research Network (1) · University of Southern California (1)
United States (8) · Canada (1) · Chile (1) · Colombia (1) · Ireland (1) · Mexico (1) · Peru (1) · Puerto Rico (1) · South Korea (1)
Amanda N Fader (1) · Anne Reb (1) · Emese Zsiros (1) · Emese Zsiros, MD, PhD (1) · Kimberly Miller, PhD (1) · Laleh Melstrom (1) · Laura Chambers, DO (1) · Meghna S Trivedi (1)
P30CA033572 (2), P50CA159981 (2), P30CA014089 (1), R21CA293326 (1), R37CA256867 (1), U10CA180868 (1), UG1CA189974 (1)